Key facts
- Motive Health’s last known valuation is $17.0M (Jan 2023).
- It has raised $59.6M across 1 recorded rounds; the latest was Early Stage VC ($15.0M) in Nov 2023.
- Notable investors include Irving Investors, Aphelion Capital, California Technology Ventures, Research Corporation Technologies.
- Motive Health has filed 3 Form Ds with the SEC since 2023, most recently Apr 2025 ($12.5M sold to 9 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Motive Health
Funding rounds
1 roundsAbout Motive Health
Developer of FDA-cleared neuromuscular electrical stimulation devices designed to relieve joint and lower back pain by strengthening stabilizing muscles. The company offers doctor-designed, app-controlled therapy devices for knee and lower back use featuring powered muscle stimulation, clinically supported treatment protocols, wearable ergonomic design, and guided therapy sessions, enabling adults managing arthritis and musculoskeletal discomfort to rebuild muscle strength, improve joint stability, and achieve lasting drug-free relief at home.
- Sector
- Healthcare
- HQ
- Scottsdale, AZ, United States
- Founded
- 2013
- Employees
- 11
- Website
- mymotive.com/
- Ownership
- Privately Held (backing)
Motive Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Motive Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Motive Health in its N-PORT filings yet. We sweep new filings monthly.